5 Amino 1MQ Peptide

A note on use: 5-Amino-1-MQ remains unapproved by the FDA for human consumption. The material presented on this page is for research and educational use only and should not be interpreted as medical advice or a recommendation for personal use.

5-Amino-1-MQ is an experimental, laboratory-made chemical being studied for weight loss, anti-aging, and muscle preservation. Scientists are researching 5-Amino-1-MQ to help adults fight severe obesity, rebuild aging muscles, and reverse chronic fatigue.

By blocking a specific fat-storing enzyme, this experimental compound helps cells burn extra calories and process blood sugar more efficiently. Researchers hope it can prevent dangerous liver fat accumulation, restore lost muscle strength in older adults, and boost overall energy levels at the cellular level.

5-Amino-1-MQ improves insulin sensitivity by helping your cells remove glucose from the bloodstream and burn it for energy. This process lowers blood sugar levels and prevents the body from storing excess sugar as fat. However, the compound does not affect ghrelin, the hormone that controls your appetite. Instead of making you feel less hungry, it causes weight loss strictly by speeding up your metabolism from inside the cells.

Key Benefits of 5-Amino-1-MQ

• 5-Amino-1-MQ Supports fat metabolism and may promote fat loss in research settings
• Helps improve cellular energy production through NAD+ preservation pathways
• Supports metabolic function and energy efficiency
• May help preserve lean muscle during calorie deficit conditions
• 5-Amino-1-MQ Supports activation of key energy-regulating pathways like AMPK
• Helps improve mitochondrial function and cellular performance (in research models)
• 5-Amino-1-MQ supports healthier glucose and lipid metabolism markers in studies
• May enhance overall metabolic health and energy balance in experimental use

Uses of 5-Amino-1-MQ

• Supports research into fat metabolism and energy production
• Studied for its role in reducing body fat and improving metabolic function
• Investigated for potential support in age-related muscle loss (sarcopenia)
• Explored for improving cellular energy efficiency
• Used in experimental longevity and anti-aging research
• Studied for its effects on glucose and lipid metabolism
• May support overall metabolic health in research settings
• Used in performance and fitness-related experimental studies

Trade Names in the USA and Manufacturers

• 5-Amino-1-MQ has no FDA-approved brand names
• It is not sold as a prescription medication
• Manufactured only as a research chemical
• Distributed by peptide and research suppliers such as:
  • Peptide Sciences
  • Core Peptides
  • Limitless Life Nootropics
• Products are labeled “for research use only”
• No official pharmaceutical manufacturer produces it

5-Amino-1MQ Dosage

What Determines 5-Amino-1MQ Dosage?

• Administration Route: Oral capsules require much higher milligram doses than subcutaneous injections.
• Research Goals: Metabolic studies often use higher doses than initial tolerance tests.
• Individual Tolerance: Researchers always start with a low dose to assess individual response.
• Note: Unlike many other peptides, body weight is not the primary driver for 5-Amino-1MQ dosing.

Daily and Monthly Dosage Breakdown

• 24-Hour Dose: 50 mg to 150 mg per day.
• Monthly Dose: 1,500 mg to 4,500 mg per 30-day cycle.

• 24-Hour Dose: 2.5 mg to 5 mg per day.
• Monthly Dose: 75 mg to 150 mg per 30-day cycle. (Note: This requires 2 to 3 vials per month).

Goal-Specific (Problem-Wise) Dosing of 5-Amino-1MQ Dosage

• Initial Tolerance Testing: 50 mg (oral) OR 2.5 mg (subcutaneous) once daily for the first 7 days.
• Standard Metabolic Research: 100 mg (oral) once daily. This is the most common target dose in research communities.
• Advanced Research Protocols: 150 mg (oral) once daily. Researchers report diminishing returns and increased side effects above this level.

Reconstitution Guide (Subcutaneous Only)

1. Gather a 50 mg vial of 5-Amino-1MQ and bacteriostatic water.
2. Inject 3.0 mL of bacteriostatic water into the vial.
3. Swirl the vial gently. Do not shake it, as this damages the compound.
4. The final concentration is now 16.7 mg/mL.
5. For a 2.5 mg dose: Draw 0.15 mL (15 units on a standard U-100 insulin syringe).
6. For a 5 mg dose: Draw 0.30 mL (30 units on a standard U-100 insulin syringe).

5 Amino 1MQ Protocol

• Cycle Length: 8 to 12 weeks of continuous use.
• Rest Period: 4 to 6 weeks completely off. This allows the body to reset baseline NNMT activity.
• Timing: Administer the dose in the morning.
• Critical Warning: Avoid evening dosing. The compound’s metabolic activation effect frequently causes sleep disruption.

Who Should Avoid This Compound?

• Pregnant or breastfeeding individuals.
• Individuals with active cancer or a recent cancer history.
• Individuals with liver disease (baseline liver enzyme checks are highly recommended).
• Children and teenagers.
• Individuals taking methyl-donor-sensitive medications (e.g., methotrexate, high-dose methylated B-vitamins).
• People with known sleep disorders.

Pricing

• Considered a premium research compound
• A typical bottle contains 30–60 capsules
• Each capsule usually contains around 50 mg
• Price range is approximately:
  • $90 to $160 per bottle
• Cost depends on:
  • Supplier
  • Purity level
  • Quantity purchased
• Long-term use can be expensive

Does any Insurance Plan Covers 5-Amino-1-MQ?

As a research compound it is not covered by any health insurance plan.

• This includes:
  • Private insurance
  • Medicare
  • Medicaid
• Classified as a research chemical or non-approved compound
• Users must pay 100% out of pocket
• No reimbursement options are available

Tips

• Store capsules in a cool, dry place
• Keep away from heat, light, and moisture
• Use airtight containers for stability
• Track health markers during use (in research settings), such as:
  • Blood glucose
  • Lipid levels
• Only use products tested by third-party labs (HPLC testing)
• Avoid late evening dosing to prevent sleep disruption

Side Effects of 5-Amino-1-MQ

• Mild nausea or stomach discomfort
• Increased heart rate in some users
• Feeling warm due to increased metabolism
• Possible sleep disturbances if taken late
• Mild digestive changes
• Effects vary based on individual response
• Long-term safety is not well studied

Contraindications of 5-Amino-1-MQ

• Avoid in people with serious heart disease
• Not recommended for those with arrhythmias
• Avoid in severe liver or kidney disease
• Not suitable during pregnancy
• Not suitable during breastfeeding
• Avoid use if on strong metabolic or insulin-altering medications
• Should only be used under medical supervision in high-risk individuals

Pharmacology of 5-Amino-1-MQ

Parameter	Specification
Systematic IUPAC Name	5-amino-1-methylquinolin-1-ium
Molecular Formula	C10H11N2+
Monoisotopic Mass	159.0917 Da
Core Scaffold	Methylated Quinolinium Ring
Primary Target	Nicotinamide N-Methyltransferase (NNMT)

• 5-Amino-1-MQ is a small synthetic quinolinium compound
• It is not a peptide
• It works by inhibiting the NNMT enzyme
• NNMT is involved in metabolic regulation and fat storage
• Inhibition helps preserve NAD+ levels in cells
• Supports energy metabolism and cellular function pathways
• Influences key metabolic signaling systems

Mechanism of Action

• Blocks Nicotinamide N-methyltransferase (NNMT)
• Prevents breakdown of nicotinamide-related metabolites
• Helps increase intracellular NAD+ levels
• Activates SIRT1 signaling pathways
• Supports AMPK activation (energy regulation pathway)
• May improve mitochondrial function and energy output
• Promotes increased fat oxidation in research models

Result Claims from Different Companies

• Claimed to support rapid fat loss
• Marketed for improved metabolic rate
• Promoted for preserving lean muscle mass
• Claimed to improve cholesterol balance
• Some claim enhanced energy and endurance
• Marketed as a “metabolic reset” compound
• Claimed benefits are not confirmed in large clinical trials

Disclaimer

• This information is for educational purposes only
• 5-Amino-1-MQ is not FDA-approved
• It is not intended to diagnose, treat, cure, or prevent disease
• Human safety data is limited
• Always consult a qualified healthcare professional before use
• Individual responses may vary

Research & Published Studies

• A small-molecule inhibitor of NNMT (nicotinamide N-methyltransferase), not a peptide in the strict sense, though it is commonly sold alongside research peptides
• NNMT regulates cellular NAD+ and SAM (S-adenosylmethionine) levels, with particularly notable activity in adipose (fat) tissue
• Preclinical research, including work associated with Mayo Clinic investigators, has studied NNMT inhibition in mouse models of obesity, linking it to reduced fat cell size independent of changes in food intake
• Mechanism of interest connects to broader NAD+ metabolism research, since NNMT consumes methyl groups that would otherwise be available for NAD+-related pathways
• Human clinical trial data is very limited; the majority of published findings come from cell culture and rodent studies

Frequently Asked Questions

Is 5-Amino-1MQ a peptide?

No. It is a small molecule compound, though it is frequently sold and researched alongside peptides in the same product category.

What is NNMT and why does it matter?

NNMT is an enzyme that regulates cellular NAD+ and fat metabolism. Inhibiting it is the basis for most 5-Amino-1MQ research.

Interactive 3D Structural Analysis and Conformational Model of 5-Amino-1-Methylquinolinium

Findings are primarily from preclinical (cell and animal) studies on fat cell size regulation. Controlled human data remains limited.